15 research outputs found
Impact of the COVID-19 pandemic on routine HIV care and antiretroviral treatment outcomes in Kenya: A nationally representative analysis
Effect of the SARS-CoV-2 pandemic, defined as the period after the first documented case when compared to the period prior to the pandemic, on virologic non-suppression amongst HIV infected individuals >15 years starting combination antiretroviral therapy using data from the national data warehouse sampling framework in Kenya (April 01<sup>st</sup> 2018 to March 31<sup>st</sup> 2021, N = 7,406)<sup>b'*'</sup>.
Effect of the SARS-CoV-2 pandemic, defined as the period after the first documented case when compared to the period prior to the pandemic, on virologic non-suppression amongst HIV infected individuals >15 years starting combination antiretroviral therapy using data from the national data warehouse sampling framework in Kenya (April 01st 2018 to March 31st 2021, N = 7,406)b'*'.</p
Distribution of HIV infected individuals >15 years old, starting combination antiretroviral therapy, included in the national data warehouse sampling framework and randomly sampled, by COVID-19 exposure status in Kenya (April 2018 to March 2021, N = 7,046).
Distribution of HIV infected individuals >15 years old, starting combination antiretroviral therapy, included in the national data warehouse sampling framework and randomly sampled, by COVID-19 exposure status in Kenya (April 2018 to March 2021, N = 7,046).</p
Overall effect of the COVID-19 pandemic, defined as period after the first documented case when compared to the period prior to the pandemic, on initial virologic non-suppression (VnS) amongst HIV infected individuals aged >15 years using data from the national data warehouse sampling framework in Kenya (April 2018 to March 2021, N = 7,046).
Overall effect of the COVID-19 pandemic, defined as period after the first documented case when compared to the period prior to the pandemic, on initial virologic non-suppression (VnS) amongst HIV infected individuals aged >15 years using data from the national data warehouse sampling framework in Kenya (April 2018 to March 2021, N = 7,046).</p
Fig 4 -
(a) Graph showing six-months retention after ART initiation by COVID-19 exposure calendar period when compared to the period prior to the pandemic, and (b) by high infection zone counties, amongst HIV infected individuals >15 years using data from the national data warehouse sampling framework in Kenya (April 01st 2018 to March 31st 2021, N = 7,046).</p
Effect of the COVID-19 pandemic, defined as the period after the first documented case when compared to the period prior to the pandemic, on time from a HIV diagnosis to combination antiretroviral therapy start (Same-day HIV diagnosis and ART initiation) amongst HIV infected individuals aged >15 years using data from the national data warehouse sampling framework in Kenya (April 01<sup>st</sup> 2018 to March 31<sup>st</sup> 2021, N = 7,046)<sup>b'*'</sup>.
Effect of the COVID-19 pandemic, defined as the period after the first documented case when compared to the period prior to the pandemic, on time from a HIV diagnosis to combination antiretroviral therapy start (Same-day HIV diagnosis and ART initiation) amongst HIV infected individuals aged >15 years using data from the national data warehouse sampling framework in Kenya (April 01st 2018 to March 31st 2021, N = 7,046)b'*'.</p
A comparison of the general eligible and randomly sampled population of HIV infected individuals aged >15 years at the start of combination antiretroviral therapy using data from the national data warehouse (April 01<sup>st</sup> 2018 to March 31<sup>st</sup> 2021, N = 352,322).
A comparison of the general eligible and randomly sampled population of HIV infected individuals aged >15 years at the start of combination antiretroviral therapy using data from the national data warehouse (April 01st 2018 to March 31st 2021, N = 352,322).</p
Fig 5 -
(a) Graph showing initial virologic non-suppression (viral load >1000 copies/ml) after ART initiation by COVID-19 exposure calendar period when compared to the period prior to the pandemic, and (b) by high infection zone counties, amongst HIV infected individuals >15 years using data from the national data warehouse sampling framework in Kenya (April 01st 2018 to March 31st 2021, N = 7,046).</p
Overall effect of the COVID-19 pandemic, defined as period after the first documented case when compared to the period prior to the pandemic, on time from a HIV diagnosis to combination antiretroviral therapy start (Same day ART initiation) amongst HIV infected individuals aged >15 years using data from the national data warehouse sampling framework in Kenya (April 2018 to March 2021, N = 7,046).
Overall effect of the COVID-19 pandemic, defined as period after the first documented case when compared to the period prior to the pandemic, on time from a HIV diagnosis to combination antiretroviral therapy start (Same day ART initiation) amongst HIV infected individuals aged >15 years using data from the national data warehouse sampling framework in Kenya (April 2018 to March 2021, N = 7,046).</p
Overall effect of the COVID-19 pandemic, defined as period after the first documented case when compared to the period prior to the pandemic, on attrition from combination antiretroviral therapy start amongst HIV infected individuals aged >15 years using data from the national data warehouse sampling framework in Kenya (April 2018 to March 2021, N = 7,046).
Overall effect of the COVID-19 pandemic, defined as period after the first documented case when compared to the period prior to the pandemic, on attrition from combination antiretroviral therapy start amongst HIV infected individuals aged >15 years using data from the national data warehouse sampling framework in Kenya (April 2018 to March 2021, N = 7,046).</p